REGN vs TH · P/E 14, rev $14.34B vs rev $386.3M
Regeneron Pharmaceuticals Inc (REGN) versus Target Hospitality Corp (TH) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Target Hospitality Corp (TH) is a specialty business services company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TH revenue for 2024-12-31 was $386.3M. Net income was $71.4M. Revenue was down 31.5% from 2023-12-31 to 2024-12-31. TH currently screens at market cap $1.93B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TH currently screens at market cap $1.93B.
Not investment advice. Open the REGN and TH stock pages for the full models.
Not investment advice.